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INTRODUCTION
The addition of N-linked glycans to newly
synthesized polypeptide chains occurs in the
endoplasmic reticulum (ER). Here the 14-sac-
charide core glycan (Fig. 1), Glc3Man9GlcNAc2,
is added to the growing nascent polypeptide
chain from a dolicholpyrophosphate-linked
precursor in a reaction catalyzed by the
oligosaccharyl transferase complex (1,2). The
modified asparagine side chain occurs within
the Asn-Xxx-Ser/Thr consensus sequence,
where Xxx denotes any amino acid except pro-
line (3). Although only relatively few of the
soluble ER-resident proteins seem to be glyco-
sylated, the majority of extracellular proteins
produced in mammalian cells carry N-linked
glycans (4). The large number of different gly-
coproteins that traffic through the ER are
involved in many fundamental intra- and inter-
cellular processes. Consequently, mutations in
Calnexin, Calreticulin, and ERp57
Teammates in Glycoprotein Folding
Lars Ellgaard* and Eva-Maria Frickel
Institute of Biochemistry, ETH Zurich, CH-8093 Zurich, Switzerland
Abstract
In eukaryotic cells, the endoplasmic reticulum (ER) plays an essential role in the synthesis and
maturation of a variety of important secretory and membrane proteins. For glycoproteins, the ER
possesses a dedicated maturation system, which assists folding and ensures the quality of final
products before ER release. Essential components of this system include the lectin chaperones cal-
nexin (CNX) and calreticulin (CRT) and their associated co-chaperone ERp57, a glycoprotein spe-
cific thiol-disulfide oxidoreductase. The significance of this system is underscored by the fact that
CNX and CRT interact with practically all glycoproteins investigated to date, and by the debilitat-
ing phenotypes revealed in knockout mice deficient in either gene. Compared to other important
chaperone systems, such as the Hsp70s, Hsp90s and GroEL/GroES, the principles whereby this
system works at the molecular level are relatively poorly understood. However, recent structural
and biochemical data have provided important new insights into this chaperone system and pre-
sent a solid basis for further mechanistic studies. 
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proteins of the N-glycosylation pathway are
known to cause severe disease phenotypes, and
a number of congenital disorders of glycosyla-
tion are known (5,6).
The sugar itself can directly modulate pro-
tein structure and function, e.g., by increasing
properties such as stability and solubility
(7–11). In addition, N-linked glycans act as
tags in intracellular trafficking (12), and
accordingly different lectins act as sorting
receptors in the secretory pathway (13–15).
Despite the many different and widely recog-
nized functions of N-linked glycans, the role of
the N-linked glycan in protein folding in the
ER has only become fully appreciated within
the past 10 yr. Specifically, it has been found
that modifications of the core glycan to gener-
ate a monoglucosylated (Glc1Man9GlcNAc2)
form determine the interaction with two
homologous lectin chaperones, calnexin
(CNX) and calreticulin (CRT).
Studies in tissue culture cells and ER-
derived microsomes have demonstrated that
the interaction with CNX and CRT protects
glycoproteins from aggregation and prema-
ture degradation (16–20). Repeated cycles of
binding to and release from CNX and CRT,
controlled by enzymes that modify the core
oligosaccharide, ensure the retention of sub-
strate glycoproteins in the favorable folding
environment of the ER until correctly folded.
If permanently misfolded, these substrate
proteins are degraded. At least for certain gly-
coproteins, the removal of a mannose residue
in the middle branch of the glycan is a signal
for degradation (21). A recently discovered
mannose-binding lectin, EDEM, specifically
accelerates the degradation of glycoproteins
and could well be directly involved in target-
ing Man8GlcNAc2-containing proteins for
degradation (22–28). Overall, the oligosaccha-
ride and the different enzymes that modify it
play important roles in glycoprotein folding
and degradation. These aspects have been
covered in great detail in other reviews
(29–33).
Cell biological studies have provided most
of our current knowledge about the
CNX/CRT chaperone system. However, more
recent work has revealed structural informa-
tion at atomic resolution for both CNX and
CRT, along with details about their interaction
with the co-chaperone ERp57. Moreover,
other studies have explored the possibility
that protein–protein interactions, in addition
to the glycan-mediated interaction, contribute
to the function of CNX and CRT as molecular
chaperones. Taken together, these investiga-
tions have considerably increased our under-
standing of the molecular basis for
glycoprotein folding and have also raised
interesting new questions. This review
describes the function of the CNX/CRT chap-
erone system. In particular, we emphasize the
role of molecular properties of CNX, CRT, and
ERp57 in determining the mechanism of chap-
erone function in the living cell.
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Fig. 1. Schematic representation of the N-
linked core oligosaccharide attached to an
asparagine side chain in an Asn-Xxx-Ser/Thr
amino acid consensus sequence. The linkage
for each individual glycosyl residue is indi-
cated along with cleavage sites for various ER
enzymes that modify the sugar structure.
ER QUALITY CONTROL
The endoplasmic reticulum (ER) plays a fun-
damental role in the synthesis, folding, and
assembly of numerous important proteins, such
as cell-surface receptors, membrane channels,
extracellular matrix components, serum pro-
teins, and antibodies. The environment in the ER
is optimal for the correct folding and maturation
of such proteins. For many proteins the matura-
tion process involves co- and posttranslational
modifications, such as signal-peptide cleavage,
glycophosphatidylinositol (GPI)-anchor addi-
tion and N-linked glycosylation. Furthermore,
the oxidizing milieu of the ER supports the for-
mation of disulfide bonds. This stabilization of
protein conformation is likely to help proteins
maintain their structure in the extracellular envi-
ronment. Finally, the ER is rich in chaperones
and enzymes, which are crucial in assisting the
process of correct protein folding (34,35).
Still, incorrectly folded or incompletely
assembled proteins are common side products
during protein synthesis in the ER. Such prod-
ucts, which could be harmful to the cell if
allowed to proceed along the secretory pathway
to the cell surface or another cellular location, are
subject to a stringent quality control (QC) system
(36,37). A number of general chaperones, includ-
ing BiP, a member of the Hsp70 family of chap-
erones, and protein disulfide isomerase (PDI), a
thiol-disulfide oxidoreductase, recognize and
retain proteins that expose non-native features.
This system ensures that misfolded and incor-
rectly assembled proteins are retained in the ER
and eventually degraded. Many so-called ER
storage diseases are known, which arise from the
ER retention of mutant alleles of certain proteins.
Such diseases include cystic fibrosis and emphy-
sema (for reviews, see refs. 38–41).
Defective ER-retained proteins are typically
degraded by the proteasome after selective
retrotranslocation to the cytosol and ubiquitina-
tion (42). This process is referred to as ER-asso-
ciated degradation (ERAD). Moreover, the cell
responds to increased misfolding of proteins in
the ER by the unfolded protein response (UPR)
(reviewed in ref. 43). Signaling from the ER to
the nucleus leads to increased transcription of
genes encoding ER chaperones to help alleviate
the folding problem. In addition, another sig-
naling pathway involving phosphorylation of
the translation initiation factor eIF2α leads to
attenuation of protein translation to further
reduce the load on the ER folding machinery.
Lastly, yet other genes involved in degradation
are upregulated, as recently shown in the case
of EDEM (28). Several investigations show that
the processes of ERAD and UPR are closely
coordinated (44–46).
THE CALNEXIN/CALRETICULIN CYCLE
The QC system described above applies to all
proteins that encounter the lumen of the ER or
are inserted into the ER membrane. CNX, CRT,
and ERp57 are important factors of this general
ER QC system (47). 
CNX and CRT cooperate with a number of
enzymes in the process of assisting glycopro-
tein folding. The first step of this so-called
CNX/CRT cycle (see Fig. 2) involves binding to
either chaperone through the monoglucosy-
lated glycan, Glc1Man9GlcNAc2, present on
nascent chains and on newly synthesized gly-
coproteins. This form of the sugar appears
either as a trimmed intermediate of the triglu-
cosylated core oligosaccharide or by readdition
of a glucose residue to the fully deglucosylated
glycan (see below). Sequential trimming of the
two outermost glucose residues on the core
oligosaccharide is executed by glucosidases I
and II. The importance of monoglucosylation
for CNX and CRT binding has been shown in
living cells, in microsomes and in vitro for a
number of different proteins (see for instance
refs. 48–56). Many such studies have used
inhibitors of glucosidase II, such as cas-
tanospermine and deoxynojirimycin, to pre-
vent the formation of the monoglucosylated,
trimmed intermediate of the original core
oligosaccharide. Under these experimental con-
ditions, access to CNX and CRT is prevented
and proteins are retained in the ER where they
often form high molecular weight complexes
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and eventually are targeted for degradation. In
addition to the initial binding through the
monoglucosylated glycan, protein–protein
interactions of CNX and CRT with their sub-
strates could well contribute to the chaperone
function of both proteins (see below) (57,58).
The process of disulfide bond formation in
glycoprotein substrates of CNX and CRT is
assisted by the thiol-disulfide oxidoreductase
ERp57, which is found noncovalently associated
with both proteins in vivo (47,59,60). The impor-
tance of ERp57 in the CNX/CRT cycle has
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become apparent from studies showing that the
protein interacts with soluble secretory proteins,
as well as integral membrane proteins, carrying
N-linked glycans (59,61). As observed for sub-
strates of CNX and CRT, both the association
and release of substrates from ERp57 are modu-
lated by glucose trimming (61–63). That the
addition of glucosidase inhibitors can result in
impaired disulfide bond formation was recently
shown in the case of CD1d heavy chain, which
interacts with CNX and CRT during folding
(64). Furthermore, the direct involvement of
ERp57 in the oxidative folding of glycoproteins
is evident from the finding that the protein
forms transient mixed disulfides with CNX- and
CRT-associated glycoproteins during folding in
living cells (63). Thus, by interacting with CNX
and CRT, ERp57 functions as a specialized thiol-
disulfide oxidoreductase for glycoproteins.
Glycoproteins are released from CNX and
CRT by the action of glucosidase II, which
removes the terminal glucose of the glycan
(49,54). This step most likely occurs irrespective
of the folding state of the glycoprotein, and pre-
vents its renewed association with CNX and
CRT. If not correctly folded at this stage, the
glycoprotein is recognized by UDP-glucose:gly-
coprotein glucosyltransferase (GT). This
enzyme works as a folding sensor and only re-
adds a glucose residue to the oligosaccharide
on non-native glycoproteins (29). In this way,
the action of GT ensures that proteins in a mis-
folded conformation can reassociate with CNX
and CRT (52,54,65). GT has been shown to
detect misfolding on a domain level (66), and
even local folding defects in one domain can be
distinguished so that only glycans in struc-
turally destabilized regions are reglucosylated
(C. Ritter, K. Quirin and A. Helenius, personal
communication). Therefore, surveillance can
take place on a domain-by-domain basis and it
can be hypothesized that glycosylation sites in
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Fig. 2. The calnexin/calreticulin cycle. The folding of newly synthesized glycoproteins in the ER
is assisted by calnexin (CNX) and calreticulin (CRT). Both proteins bind to the monoglucosylated
form of the glycoprotein generated after the initial removal of two glucoses by glucosidases I and
II. Here, we have used the available three-dimensional structures of CNX (the lumenal domain) and
CRT (the P-domain) to depict parts of the two molecules (see also Fig. 4). The glycan binds to the
lectin domain of both chaperones—in CRT the glycan binding site is represented by the curved
black line. Other interactions can occur through protein-protein contacts (not depicted). Disulfide
bond formation in glycoprotein substrates of CNX and CRT is catalyzed by the associated thiol-
disulfide oxidoreductase ERp57, with which substrates form transient mixed disulfide intermedi-
ates. In both CNX and CRT, the tip region of the P-domain mediates the interaction with ERp57.
Removal of the remaining glucose, in a reaction catalyzed by glucosidase II, prevents interaction
with CNX and CRT. Upon release, one of three possible fates awaits the glycoprotein. First, if the
protein has reached its native conformation it is not longer retained in the ER and is free to travel
along the secretory pathway. Second, if the protein is still not correctly folded, it can be recognized
by the UDP-glucose:glycoprotein glucosyltransferase (GT). This enzyme uses UDP-glucose as a
sugar donor to reglucosylate non-native glycoproteins carrying high-mannose glycans.
Consequently, it acts as a folding sensor in CNX/CRT cycle. The readdition of a glucose residue to
the N-linked glycan promotes reassociation with CNX and CRT. An important role of CNX and
CRT is to retain glycoproteins in the ER, where the conditions for folding are favorable. Finally, pro-
longed ER-retention increases the chances of encountering the ER α1,2-mannosidase I. This enzyme
removes a mannose residue in the middle branch of the glycan to generate a form with eight man-
noses (see also Fig. 1). A novel ER lectin, EDEM, is likely to recognize this form of the glycan and
thereby extract the glycoprotein from the CNX/CRT cycle. Moreover, EDEM directs the glycopro-
tein for degradation by the ERAD pathway.
domains with a tendency for misfolding have
been maintained throughout evolution in order
to optimize the folding efficiency of glycopro-
teins carrying such domains.
Overall, cycles of binding and release slow
down the rate of folding but increase its effi-
ciency for many glycoproteins by keeping them
exposed to the ER QC system (20). Like other
protein QC systems in the cell, the detection of
non-native glycoproteins in the ER by GT relies
on features of the polypeptide chain that distin-
guish it from proteins in a native conformation.
The benefit of using sugars as “reporter mole-
cules” for the protein folding status likely
relates to the fact that the modifications of the
core oligosaccharide that control the fate of gly-
coproteins in the ER are independent of the spe-
cific protein. Thereby the glycan, which is
present in a large number of molecules, works
as a highly versatile tag that can be modified
and recognized by a relatively small number of
ER-resident enzymes and lectins. 
SUBSTRATE INTERACTIONS 
OF CALNEXIN AND CALRETICULIN
A wide variety of important cellular and viral
glycoproteins are known substrates of CNX and
CRT. These include HIV gp120 and gp160
(67–70), class I major histocompatibility com-
plex (MHC) heavy chain (17,71–77), T-cell recep-
tor subunits (71,78), α1-antitrypsin (50,79,80),
tyrosinase (81–83), the prion protein (84,85), and
the cystic fibrosis transmembrane conductance
regulator (CFTR) (86,87). Although many glyco-
proteins associate with both CNX and CRT, and
despite having the same glycan specificity, these
two lectins can have distinct roles in glycopro-
tein maturation. For instance, they can bind to
the same protein at different stages of the fold-
ing process as seen for both the MHC class I
heavy chain (88,89) and influenza hemagglu-
tinin (HA) (18). For the latter, association has
been shown to depend on the position of the
sugar within the molecule. Whereas CRT associ-
ates preferentially with the glycans of the HA
top domain, CNX associates more efficiently
with those glycans present in the membrane-
proximal stem domain (90).
The set of substrates bound by the two pro-
teins is largely, but not completely, overlapping
(51,91). In line with the results obtained for
HA, the difference in substrate recognition pat-
tern has been shown to depend on the presence
of the membrane anchor in CNX (92,93).
However, the finding that the lumenal domain
of CNX cannot complement the function of
CRT in MHC class I assembly when expressed
in CRT-deficient cells indicates that the two
proteins possess protein specific functions
despite their many similarities (76).
As mentioned previously, the exact mode of
interaction by CNX and CRT with their glyco-
protein substrates is not entirely clear. Studies
performed in vitro using RNaseB as a model
glycoprotein and studies of glycoprotein folding
in the protozoan parasite Trypanosoma cruzi sug-
gest that the function of CNX and CRT as mole-
cular chaperones can be attributed solely to
their lectin activity (53,55,94). However, assays
of aggregation and refolding using purified pro-
teins as substrates show that CNX and CRT
could have an additional function as classical
chaperones, characterized by protein–protein
contacts with hydrophobic regions exposed by
non-native polypeptide chains (57,58). As
observed for classical chaperones, CNX and
CRT can suppress aggregation and preserve
proteins in a folding competent state, indepen-
dent of their glycosylation status (monogluco-
sylated or nonglycosylated) (57,58). However,
the efficiency of suppressing aggregation
was enhanced for monoglucosylated proteins,
potentially indicating an avidity effect of two
binding sites, one for the glycan and one for
the polypeptide chain of the substrate (95).
Whereas native conformers were shown not to
interact with CNX and CRT, complexes were
formed with misfolded conformers.
The effects of cofactors, such as Zn2+, adeno-
sine triphosphate (ATP) and the monoglucosy-
lated glycan on this bonafide chaperone
function of CNX and CRT, have also been
investigated in vitro. These cofactors are
known to modulate structural properties of
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CNX and CRT (see below). Although ATP was
shown to enhance the ability to suppress pro-
tein aggregation, addition of the monoglucosy-
lated glycan inhibited this function (57,58). The
latter result indicated that occupation of the
oligosaccharide binding site is capable of influ-
encing the protein–protein interactions pro-
posed to mediate the chaperone function.
Overall, these experiments support the
notion that protein–protein based contacts of
CNX and CRT with their substrates, in addi-
tion to an initial glycan based interaction, play
an important role during folding (57,58).
Moreover, ATP binding by CNX and CRT, and
potentially Zn2+ binding in the case of CRT,
could promote substrate interaction by lead-
ing to the exposure of hydrophobic surface.
Substrate release would then occur by ATP
hydrolysis or dissociation, both processes pos-
sibly mediated by a co-chaperone.
MOLECULAR PROPERTIES 
OF CALNEXIN AND CALRETICULIN
Besides its well-established role as a molecu-
lar chaperone, CRT is a major Ca2+ storage pro-
tein and plays an important role in Ca2+
homeostasis in the ER (96,97). Thus, the embry-
onic lethal phenotype observed in CRT-deficient
mice is connected to the function of the protein
in Ca2+ signaling during cardiac development
(99,100). Although CNX also binds Ca2+
(101,102), the protein does not seem to play a
significant role in Ca2+ homeostasis and its
major function is that of a molecular chaperone.
CNX gene-deficient mice do not show as serious
defects as CRT knockout mice. However, 50%
die within 2 d of birth, whereas the rest display
severe motor disorders, a selective loss of large
myelinated fibers and die within 3 mo (103).
Biochemical studies of CNX and CRT are
abundant, and below the most important bio-
chemical properties of the two proteins are
summarized. Together with structural data,
these molecular characteristics constitute the
basis for understanding the mechanism of
chaperone function of CNX and CRT in detail.
Primary Structure 
The molecular cloning of CRT (46.5 kDa, 400
residues) (104,105) and CNX (65.4 kDa, 572
residues) (101,102) has revealed that the two
proteins are highly similar (Fig. 3). The main
differences are found in their carboxyl termi-
nal regions. Whereas CRT is a soluble luminal
protein with a carboxyl terminal KDEL
retrieval sequence, CNX is a type I transmem-
brane protein with a predicted transmem-
brane region spanning residues 463–485,
followed by a 87-residue carboxyl terminal
cytosolic tail. However, the luminal domain of
CNX is highly similar to CRT. Based on
sequence analysis, both proteins have been
suggested to consist of three regions, the N-, P-,
and C-domains (Fig. 4) (104–107). The N-
domain (CRT residues 1–188, CNX residues
1–253) was originally predicted to comprise a
β-sheet rich globular structure (104,105). The
unique P-domain (CRT residues 189–283, CNX
residues 254–388) constitutes the signature
sequence for this family of proteins, and has
obtained its name due to the many prolines
present in this region. It consists in its entire
length of two short sequence repeats, the type
1 and type 2 repeats. Each type of repeat is
present in three and four copies in CRT and
CNX, respectively. In both proteins, the
arrangement of the repeat sequences is such
that all type 1 repeats are clustered together,
followed by a cluster of type 2 repeats (Figs. 3
and 4). The distinguishing feature of the CRT
C-domain (residues 284–400) is the enrich-
ment of acidic amino-acid residues in the
approx 60 carboxyl terminal residues. This
region is known to play a role in low-affinity
Ca2+ binding (106,108,109). In contrast, the C-
domain of CNX, residues 389–462, does not
display noticeable traits. Here, the membrane-
proximal region of approx 20 residues is likely
to represent a linker sequence between the
membrane anchor and a globular lectin
domain (see below).
The sequences of both CNX and CRT encode
cysteine residues that form intrachain disulfide
bonds. In CNX the four cysteines pair to form
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Fig. 3. Amino-acid sequence alignment of human CNX and human CRT. Both sequences are
shown without amino terminal signal sequences and numbered accordingly. Repeat sequences of
the P-domain are indicated above the alignment. Amino-acid residues proposed to coordinate Ca2+
in the crystal structure of the lumenal domain of CNX are labeled with an asterisk, and amino-acid
residues proposed to interact with the glycan are marked with a triangle. The black bar denotes the
transmembrane region in CNX. Boundaries for the NMR structure of the CRT P-domain (residues
189–288) and for the crystal structure of the lumenal domain of CNX (residues 40–437) are indicated
above and below the respective sequences with arrows.
Fig. 4. Overview of the primary amino-acid sequence of CNX and CRT, and the three-dimen-
sional structures solved for the two proteins. In the schematic representation, the position of
type 1 and type 2 repeats of the P-domain is indicated along with the position of free and disul-
fide-bonded cysteine residues. ‘TM’ denotes the transmembrane region in CNX. The arrows
indicate the boundaries of the fragments for which the three-dimensional structures are shown
below. In the representation of the three-dimensional structure of the lumenal domain of CNX,
residues involved in the binding of the glucose are shown as black stick models and the cys-
teines forming the two disulfide bonds are shown as CPK models. This figure was prepared
using the program MOLMOL.
the Cys140–Cys174 and Cys340–Cys346 disul-
fides (110). In CRT a free cysteine is present at
position 146, whereas the Cys89–Cys120 disul-
fide is equivalent to the Cys140–Cys174 disul-
fide in CNX (111). Although certain animal
CRT sequences contain a conserved N-glycosy-
lation site at residue 326, human placental CRT
has been shown not to be glycosylated (111).
Animal CNXs do not contain potential sites for
N-linked glycosylation. A unique feature of the
carboxyl terminal cytosolic tail of CNX is the
presence of sites for phosphorylation by casein
kinase II at Ser534 and Ser544 and by extracel-
lular-signal regulated kinase-1 at Ser563
(112,113). Phosphorylation at these positions
has been shown to regulate the association of
CNX with ribosomes (114). 
Both CNX and CRT have a tissue-specific
isoform in testis. The CNX isoform, calmegin,
interacts with nascent chains of glycoproteins
and is required for male fertility in mice
(115,116), whereas the function of the recently
discovered CRT isoform, CRT2, has not yet
been investigated (117). The sequence similar-
ity of both testis isoforms with the respective
ubiquitously expressed forms is high (>60%),
and it is very likely that the isoforms also func-
tion as lectin chaperones (117–119).
Ca2+ Binding 
Different cofactors have been found to inter-
act with CNX and CRT in vitro and thereby
modulate the structural properties of both pro-
teins. The effects of metal binding by CRT have
been thoroughly characterized by a variety of
methods, such as circular dichroism, intrinsic
fluorescence, 8-anilino-1-naphtalenesulfonate
(ANS) binding and equilibrium dialysis. Of
twelve different divalent cations tested for
binding to CRT, only Ca2+ and Zn2+ were
shown to bind specifically (109). CNX binds
Ca2+ (101,102,120,121), whereas there is little
evidence that the protein binds other metals. 
Owing to its role in Ca2+ homeostasis, the
Ca2+-binding properties of CRT have been par-
ticularly well investigated (see for instance,
refs. 106,108,109,122–125). The protein has two
distinct classes of binding sites: one high-affin-
ity binding site that complexes 1 mol Ca2+/mol
protein with a Kd of 0.05–11 µM, and several
low-affinity sites, located in the acidic C-termi-
nal domain, that bind approx 20 mol Ca2+/mol
protein with a Kd of 2 mM (106,108,109). As
pointed out earlier (107), the rather broad
range of Kd values determined for high-affinity
Ca2+ binding by CRT is likely a result of the dif-
ferent experimental conditions employed in
these studies. 
Ca2+ binding by CRT seems to have only lit-
tle effect on the content of regular secondary
structure elements and on the global structure
of the protein (109,123,125,126). However, upon
occupancy of the high-affinity Ca2+ binding
site, local structural effects are observed that
indicate a more compact conformation with
increased thermal stability (109,125). These
results can be rationalized based on the crystal
structure of the lumenal domain of CNX, which
coordinates one Ca2+ ion with a proposed role
of structural stabilization (110). In addition,
CRT shows increased resistance toward prote-
olytic digestion by a variety of proteases at high
Ca2+ concentrations (124,125). A similar result
has been reported for CNX (121).
Zn2+ Binding
CRT contains one high-affinity binding site
for Zn2+ (apparent Kd of 0.05 µM) and 14 low-
affinity binding sites (apparent Kd of 310 µM)
(109). Zn2+ binding by CRT has been mapped
to the N-domain (127) and has been shown to
induce a considerable conformational change
in the protein resulting in the exposure of
hydrophobic surface (57,109). In accordance
with these results, CRT is found to aggregate at
concentrations of Zn2+ above 600 µM (109,127),
whereas CNX aggregates already in the pres-
ence of 100 µM Zn2+ (128). In CRT the observed
conformational change is accompanied by an
increased susceptibility toward proteolytic
digestion by trypsin and chymotrypsin and a
decreased thermal stability (125).
As proposed by several authors, the expo-
sure of hydrophobic surface by CRT observed
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in vitro in the presence of concentrations as low
as 50 µM ZnCl2 could potentially be important
for the ability of the protein to suppress aggre-
gation through protein–protein interactions
with its substrates (57,124,125). Unfortunately,
although Zn2+ is present in the ER lumen, little
is known about its concentration and all the
mammalian zinc transporters described to date
are localized to cellular compartments other
than the ER. However, recent studies show that
the ER of Schizosaccharomyces pombe harbors a
zinc transporter thought to regulate ER zinc
homeostasis in this organism (129,130). 
ATP Binding
Another potentially important cofactor of
CNX and CRT is ATP. Both proteins bind ATP
in vitro (57,58,121,131). Although a weak
ATPase activity has been reported for both pro-
teins (57,58), others have been unable to detect
any such activity (121,124). For both proteins,
the binding of ATP is accompanied by a
decrease in intrinsic fluorescence emission and
enhanced binding of ANS, indicating exposure
of hydrophobic surface (57,58). Whereas the
presence of ATP protects the carboxyl terminal
region of CRT from proteolysis (124), both
destabilizing and stabilizing effects of ATP
binding by CNX have been reported (121,131). 
Currently, the physiological significance of
ATP binding by CNX and CRT remains
unclear. Classical chaperones such as those
belonging to the Hsp70 family, including the
ER-resident protein BiP, are ATPases. Cycles of
ATP binding, hydrolysis and nucleotide
exchange control substrate binding and
release, and are, in turn, regulated by cofactors
that either influence ATPase activity or act as
nucleotide exchange factors. The reported
ATPase activity of <0.1 pmol/min/µg for CNX
and CRT is very low (57,58). In comparison,
BiP, which is considered a weak ATPase, has an
activity of 5.2 pmol/min/µg (132). Thus, if
ATP hydrolysis plays a role for the chaperone
function of CNX and CRT, positive regulators
of ATPase activity and nucleotide exchange are
likely to exist.
Glycan Binding
A number of studies performed in vitro have
characterized the direct interaction of CNX and
CRT with isolated glycans using biochemical
methods. All support the notion that both
proteins are lectins that specifically interact
with the monoglucosylated form of the core
glycan (Fig. 1) (50,131,133–135). These studies
also show that CNX and CRT interact with
glycans with increasing affinity when com-
paring oligosaccharides of different lengths
as follows: Glc(G1) << Glcα1-3Man(G1M1)
<< Glcα1-3Manα1-2Man(G1M2) < Glcα1-
3Manα1-2Manα1-2Man(G1M3). Therefore, the
glycan interaction is likely to involve the entire
α1-3 branch of the oligosaccharide, which forms
a continuous molecular surface in the NMR
structure of Glc1Man9GlcNAc2 (136). Direct
affinity measurements have shown that the
G1M3 tetrasaccharide binds CRT with compara-
ble affinity to an IgG molecule carrying the entire
monoglucosylated glycan (135). However, gly-
can binding by CNX and CRT could potentially
also involve contacts to the mannose residues on
the α1-6 branch of the glycan (50,133).
Detailed biophysical analysis of the bind-
ing of IgG carrying a single monoglucosy-
lated glycan to CRT demonstrated a Kd of
approx 2 µM (137). Furthermore, this study
showed that—at least under these experi-
mental conditions using a native monogluco-
sylated protein—no contribution to the
binding reaction was observed from pro-
tein–protein interactions. As proposed by
Surolia and coworkers (137), the relatively
low affinity of CRT for the glycan could be
advantageous to allow for rounds of glyco-
protein association and dissociation. This fea-
ture would permit trimming of the remaining
glucose of the glycan by glucosidase II to
occur on the nonbound substrate. Such a
model is supported by the finding that
RNaseB bound by the lumenal domain of
CNX is protected effectively from glucosidase
II and PNGaseF digestion (53).
In vitro, the binding of the oligosaccharide
by either CNX or CRT depends critically on the
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presence of Ca2+ (131,137). Thus, it is possible
that the deleterious effect of Ca2+ depletion
from the ER, observed for the folding of glyco-
proteins known to interact with CNX and CRT,
directly reflects structural changes in the lectin
domain, which render both proteins incapable
of ligand interaction (138). 
STRUCTURAL STUDIES OF CALNEXIN
AND CALRETICULIN
The biochemically determined properties of
CNX and CRT have been put into new per-
spective by recent structural studies on both
molecules. For CNX, the crystal structure of a
fragment comprising residues 40–437, encom-
passing most of the lumenal domain, has been
reported to a resolution of 2.9 Å (Fig. 4) (110).
This highly unusual structure contains two
separate entities: a globular β-sandwich
domain homologous to legume lectins and an
extended hairpin fold of approx 140 Å in
length, corresponding to the P-domain. The
globular domain comprises a concave and a
convex β-sheet with six and seven β-strands,
respectively. In this part of the molecule, the
CNX model also shows a putative Ca2+ bind-
ing site, with the Ca2+ ion proposed to play a
role in structural stabilization rather than lig-
and interaction. The only regular secondary
structure elements in the P-domain are four
short, anti-parallel β-sheets where each β-
strand contains three residues. The disulfide
bond connecting the cysteine residues 340 and
346 is found close to the tip of the P-domain. 
By soaking the crystal in glucose and deter-
mining its location in the electron density, it
was found that the concave β-sheet of the glob-
ular domain harbors a monovalent glycan
binding site. Modeling the binding of the G1M3
tetrasaccharide indicated that steric hindrance
is likely to prevent the access of glucosidase II
to its sugar substrate. This finding supports the
idea that the glycoprotein must dissociate from
the lectin for cleavage by glucosidase II to
occur. The disulfide bond connecting the cys-
teine residues 140 and 174 is present in the glob-
ular domain where it connects two β-strands in
the vicinity of the proposed glycan-binding site.
This feature can account for the observed sensi-
tivity of oligosaccharide binding by CNX
toward reduction (121,131). 
Interestingly, legume lectins, galectins and
neurexin 1β possess a fold closely related to the
globular domain of CNX (110). The laminin G-
like domain of neurexin 1β contains alternative
splice sites in loops connecting the β-strands
and the absence or presence of inserted
sequences at these sites determines ligand
interactions (139). Similarly, the P-domain of
CNX is introduced at the same topological
position as one of the splice sites in neurexin 1β
and also establishes a protein–protein interac-
tion (see below). 
For CRT, the NMR structure of the P-domain,
residues 189–288, has been solved (Fig. 4)
(140,141). Like the CNX P-domain it shows an
extended hairpin fold, in the case of CRT with a
length of approx 110 Å. Three short antiparallel
β-sheets and three small hydrophobic clusters
stabilize the structure. This threefold repetition
of structural elements and the four-fold repeti-
tion of similar structural features in the CNX P-
domain closely reflects the repetitive nature of
the P-domain sequence in the two molecules
(Figs. 3 and 4). Roughly, each type 1 repeat
sequence pairs up with a type 2 repeat
sequence in the structure of both P-domains by
forming interactions across the hairpin. In addi-
tion, it has recently been shown that a short
fragment corresponding to one type 1 repeat
and one type 2 repeat, and comprising the β-
sheet and the hydrophobic cluster at the tip of
CRT P-domain, constitutes an independently
folding structure (142). It is tempting to specu-
late that the unique sequence of the P-domain
has evolved by the sequential insertion of such
“12” units into a loop region of the globular
lectin domain. 
Currently, the structure corresponding to the
CNX lectin domain is not known for CRT.
However, the crystal structure of the lumenal
domain of CNX and the sequence similarity
between the two proteins (Figs. 3 and 4)
strongly indicate that the CRT N-domain and
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residues 284–337 of the C-domain will form a
globular domain with structural similarity to
the CNX lectin domain. Indeed, this is exactly
what the recently modeled structure of the
CRT lectin domain also suggests (135).
Furthermore, biochemical and biophysical
analysis of full-length CRT has shown that the
molecule is asymmetric and elongated (126).
Based on this information, the known struc-
tural data for both proteins and the overall
high conservation of sequence and function
between the two proteins, it can be assumed
that both CNX and CRT show a two domain
structure comprising a globular lectin domain
and a long protruding P-domain. In addition,
the residues of CNX proposed to be involved
in the binding of glucose and Ca2+ are largely
conserved in CRT. Likewise, residues in CRT
proposed to bind the G1M3 tetrasaccharide are
well conserved in CNX (Fig. 3). 
Whereas the crystal structure of the lumenal
domain of CNX revealed the lectin function of
the globular domain, the function of the P-
domain remained unclear despite detailed
structural analysis obtained by both X-ray crys-
tallography and NMR spectroscopy. However,
it has now been shown that the P-domain of
both CNX and CRT binds to ERp57
(128,142,143). Using NMR spectroscopy and
deletion mutants of both CNX and CRT, these
studies have mapped the site of interaction with
ERp57 to the distal end of the P-domain.
Furthermore, the Kd of the interaction between
ERp57 and the CRT P-domain was determined
to approx 9 µM (142,143). Although this affinity
is quite weak, it is likely that a more stable ter-
tiary complex results in the presence of a cys-
teine-containing glycoprotein substrate through
the formation of transient mixed disulfide
bonds between the glycoprotein and ERp57.
THE ROLE OF ERP57
The growing family of ER thiol-disulfide oxi-
doreductases, most of which contain one or
more thioredoxin-like domains, promotes the
proper oxidation, isomerization and reduction
of disulfide bonds (144). The reactions involving
these proteins proceed through intermolecular
disulfide-bonded intermediates and both ERp57
and PDI form mixed disulfides with viral glyco-
proteins during folding in living cells (63).
Therefore, rather than regulating the redox state
of other factors in the ER, these proteins directly
catalyze the oxidative folding of proteins.
Molecular Studies of ERp57 
The best characterized of the redox-active
proteins in the ER is PDI. It comprises four
thioredoxin-like domains—termed a, b, b’, and
a’—followed by an acidic carboxyl terminal
c-domain, which also harbors the KDEL ER-
retention motif. Thioredoxin is a small 12 kDa
protein, which functions as a disulfide reduc-
tase in the cytosol. The three-dimensional struc-
tures of thioredoxin and related domains show
a typical α/β fold with a five-stranded β-sheet
surrounded by four α-helices (for a review, see
ref. 145). In PDI, the a and a’ domains are cat-
alytically active and both contain two cysteine
residues in a characteristic ‘CXXC’ sequence
motif. Within the thioredoxin superfamily these
cysteines are redox-active and switch between
the dithiol and disulfide forms.
ERp57 is the closest known homolog of PDI,
with which it shares the same domain composi-
tion except for the absence of the acidic c-
domain. Consequently, the QDEL ER-retention
motif in ERp57 is located directly at the car-
boxyl terminal end of the a’ domain (146). PDI
and ERp57 show an overall amino acid identity
of 29%, with the a and a’ domains being most
closely related, whereas the b’ domains are the
most divergent. In PDI, the b’ domain has been
shown to bind peptides, a feature that is likely
to be related to its function as a bonafide chap-
erone. Since the ERp57 b’ domain does not pos-
sess a similar function, it is tempting to
speculate that this domain in ERp57 could have
evolved to constitute a binding site for CNX
and CRT, as proposed recently by Freedman
and colleagues (145). Currently, no structural
data are available for ERp57. However, NMR
structures of the PDI a and b domains show
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that they both comprise typical thioredoxin-like
folds (149,150). Preliminary NMR data and
assignments have been reported for the a’
domain of ERp57 (151).
Using in vitro assays for redox activity, ERp57
has been shown to have disulfide reductase and
isomerase activity (152–155). Only one in vitro
study has investigated the catalytic activity of
ERp57 using an endogenous substrate of the
protein, namely partially folded MHC class I
heavy chain molecules (156). Toward this sub-
strate, ERp57 was shown to exhibit reductase
activity, and it was proposed that this activity
might be involved in reducing heavy chain mol-
ecules prior to retrotranslocation and degrada-
tion (156). However, it remains to been seen
exactly which type(s) of disulfide exchange
reaction(s) ERp57 performs in vivo.
PDI and Glycoprotein Folding
As mentioned previously, ERp57 acts as a
glycoprotein specific redox-active enzyme
through its cooperative interaction with CNX
and CRT. The finding that ERp57-enhanced
disulfide bond formation in vitro is dependent
on CNX and CRT stresses the functional coop-
eration of both lectin chaperones with ERp57
(157). No positive effects on glycoprotein
refolding by PDI were observed upon addition
of CNX and CRT. Although PDI has been
shown to be involved in glycoprotein folding
(63), substrate interaction of PDI in vivo is not
regulated by glucose trimming (59–61,63,158).
These studies all indicate that PDI functions
independently of CNX and CRT, which is in
agreement with findings that were unable to
detect complexes of either lectin with PDI
(60,143). However, other data have shown that
PDI interacts with CRT (123,159). It is possible
that this apparent discrepancy is a result of the
different experimental conditions used because
the interaction is strongly influenced by
changes in Ca2+ concentrations (123). Thus,
fluctuations in the free concentration of Ca2+ in
the ER could affect protein folding, either
directly by inducing conformational changes in
CNX and CRT resulting in altered substrate
interactions or indirectly by modulating the
binding of co-chaperones (97,123).
ERp57 in MHC Class I Assembly 
Recently, several investigations have focused
on the interaction of ERp57 with glycoproteins
during CNX- and CRT-dependent folding (see,
for instance, refs. 64,160–162). To date, the best-
studied glycoprotein substrate of ERp57 in vivo
is the MHC class I complex. This heterodimer is
comprised of the glycosylated heavy chain and
the associated protein, β2-microglobulin. The
MHC class I complex plays a critical role in the
immune response by delivering for instance
virus- and tumor-derived antigenic peptides to
the cell surface for presentation to receptors on
cytotoxic T-cells. The process of MHC class I
folding, assembly and peptide loading takes
place in the ER, and has been shown to involve
CNX, CRT and ERp57 together with the more
specialized proteins transporter associated with
antigen processing (TAP) and tapasin. During
the early stages of folding the newly synthe-
sized heavy chain interacts with CNX. Upon
binding of β2-microglobulin, CRT replaces CNX
and together with TAP, tapasin and ERp57 form
the so-called peptide loading complex (PLC). In
a tapasin-dependent process, the class I mole-
cules are then loaded with peptide, the PLC dis-
sociates and the mature MHC class I complex
can traffic to the cell surface (for recent reviews,
see refs. 77,163,164). 
ERp57 is involved at various stages of MHC
class I assembly. The heavy chain contains two
disulfide bonds and folds and oxidizes while
associated with CNX, but prior to incorporation
into the PLC (165–167). Because a ternary com-
plex of heavy chain, CNX and ERp57 has been
observed already at this early stage of matura-
tion, it is possible that ERp57 is involved in cat-
alyzing disulfide bond formation in the heavy
chain (167). Moreover, ERp57 is an important
component of the PLC (167). The association of
ERp57 with the PLC has been shown to be
tapasin dependent and correlate with CRT
association (169,171). The latter finding sug-
gests that a preformed complex of CRT and
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ERp57 could enter into the PLC (171). The func-
tional cooperation between ERp57 and tapasin
is stressed by the finding that the two proteins
form an intermolecular disulfide bond in the
PLC (172). Analysis of cysteine-lacking mutants
of ERp57 and tapasin has led to the conclusion
that the two proteins in concert mediate the iso-
merization and/or re-oxidation of the disulfide
bond in the peptide-binding groove of MHC
class I heavy chain (172). Although it is
presently not known exactly how this process
occurs, it has been shown to be important for
the correct loading of the MHC class I β2-
microglobulin heterodimer with high affinity
peptides (172).
FROM MOLECULAR PROPERTIES 
TO IN VIVO FUNCTION
The insight gained from the many biochem-
ical and cell biological studies of CNX, CRT
and ERp57 is providing a more and more
detailed picture of the processes involving
these three chaperones. Our understanding is
now so advanced that many functional fea-
tures observed in vivo can be rationalized
based on known biochemical and structural
properties. As described previously, the pre-
sent data strongly indicate that CNX and CRT
show a similar overall structural organization.
Functionally, the lectin domain is responsible
for binding the glycan attached to substrate
glycoproteins, whereas the P-domain binds
ERp57 at its tip. These features, in combination
with the properties of both chaperones deter-
mined in vivo, have led us to present a basic
model for the cooperative interaction of either
chaperone and ERp57 with the nascent chain
or non-native conformers of newly synthesized
glycoproteins in the ER (143,173).
We propose that substrate binding occurs
through the interaction of the monoglucosy-
lated glycan with the lectin domain of either
CNX or CRT. This feature allows the polypep-
tide chain a certain degree of conformational
freedom in the process of folding. The struc-
tural arrangement of the lectin domain and the
elongated P-domain with ERp57 bound at the
tip sequesters the polypeptide chain of the sub-
strate in a partially protected space during
folding. This partial shielding of the bound
glycoprotein substrate should help to suppress
intermolecular aggregation that could result
from interactions with other ER folding inter-
mediates. The role of the P-domain is likely to
involve positioning of ERp57 for the formation
of intermolecular disulfide bonds with a vari-
ety of bound substrate proteins. The conforma-
tional plasticity observed in the NMR structure
of the CRT P-domain could allow both chaper-
ones to adapt to substrates of varying size and
shape (140). This complements the idea that the
overall molecular flexibility of CRT character-
ized biophysically by Bouvier and colleagues is
advantageous for the protein in its function as
a molecular chaperone by allowing transient
and dynamic interactions with a number of
substrates (109,123,125,126). An additional
function of the P-domain could be to constrain
diffusion of the substrate after dissociation
from CNX and CRT. This would allow for a
more rapid reassociation, provided that the
remaining glucose on the glycoprotein sub-
strate has meanwhile not been trimmed by
glucosidase II. Taken together, the function of
CNX and CRT is likely to be dictated by their
distinctive structural features and the close
cooperation with ERp57, which leads to the
productive oxidative folding of glycoprotein
substrates.
This basic model supports the view that
CNX and CRT function as molecular chaper-
ones by keeping their substrates “out of trou-
ble” rather than by actively promoting folding.
However, it leaves room for the incorporation
of additional features of both proteins relating
to the binding of cofactors and protein–protein
contacts with substrate glycoproteins. The pre-
diction of protein–protein interactions during
CNX- and CRT-assisted glycoprotein folding is
appealing because it provides explanations for
results otherwise not easy to rationalize. For
instance, when performing immunoprecipita-
tion experiments to identify glycoprotein sub-
strates of CNX in vivo, it has been observed
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that certain complexes persist even after
removal of the glycan by glycosidase treatment
with Endo H or PNGase F (50,78,174,175).
Therefore, it could be that the initial binding of
CNX and CRT to the glycoprotein substrate
occurs as a result of the lectin activity, but that
subsequent protein-protein contacts stabilize
the complexes. Polypeptide-based contacts
could also help explain the rather high effi-
ciency observed for coimmunoprecipitation of
substrate proteins with CNX and CRT in spite
of the relatively low affinity measured for the
interaction between CRT and monoglucosy-
lated IgG (137).
Currently, however, the data relating to the
function of CNX and CRT as bona fide molecu-
lar chaperones are not easy to assess defini-
tively. For instance, the physiologic role of
potentially important cofactors implicated in
this function, such as Zn2+ and ATP, is
presently not evident. It has also been argued
that immunoprecipitation is not the method of
choice to study interactions that involve non-
native conformers or nascent chains owing to
their hydrophobic nature (29). For example,
overexpression of protein or addition of tuni-
camycin, which inhibits glycosylation and
turns on the UPR, often results in protein mis-
folding and aggregation. Potentially, com-
plexes of CNX and nonglycosylated proteins
immunoisolated under such conditions that
perturb the folding environment in the ER
lumen are nonphysiologic in nature. Besides,
interactions of membrane proteins with CNX
could possibly be preserved if caught in the
same detergent micelle (20).
The fact that the experimental conditions
employed in immunoprecipitation experiments
can influence results considerably contributes
an additional difficulty. When performing
immunoprecipitations under mild detergent
conditions (176), interaction of nonglycosy-
lated proteins or proteins carrying di- or triglu-
cosylated glycans with CNX and CRT can be
observed. In contrast, when performing similar
experiments under more stringent detergent
conditions, no binding to CNX was observed
(177). No matter which experimental condi-
tions are employed, any substrate interaction
observed with CNX and CRT should be criti-
cally assessed to ensure that it is transient and
that it results in the formation of a fully mature
and correctly folded substrate protein. Only
such interactions are expected to occur as a
result of the chaperone function of CNX and
CRT. In contrast, long-lasting interactions with
substrate proteins are likely to be nonproduc-
tive and of nonspecific nature. 
PERSPECTIVES
Since 1989 when Suh and colleagues
observed that a misfolded variant of the vesic-
ular stomatitis virus G-protein was retained in
the ER in a monoglucosylated form (178), our
understanding of the processes involved in
glycoprotein folding in the ER has increased
tremendously. In particular, the roles of the dif-
ferent proteins in the CNX/CRT cycle have
become much more evident. The publication of
three-dimensional structures of CNX and CRT
has provided substantial new insight into the
molecular mechanism of the chaperone func-
tion of these proteins and has significantly
changed the way we think about these two
lectin chaperones. 
The next goals for the field should involve
the determination of a high-resolution struc-
ture of the CRT lectin domain, if possible in
complex with the G1M3 glycan. More detailed
information about the interaction of CNX and
CRT with ERp57, as well as structure determi-
nation of ERp57, or individual domains
thereof, will be important. Additional experi-
ments will be needed to clarify the exact role of
the P-domain in glycoprotein folding. Despite
being structurally similar, the P-domains in
CNX and CRT differ with a “12” repeat unit in
size. Whether this difference also conveys func-
tional distinctions is presently unclear.
Addressing such questions relating to the P-
domain should also promote a better under-
standing of how the cooperation of CNX and
CRT with ERp57 assists disulfide bond forma-
tion in substrate glycoproteins. 
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The direct mapping of specific residues in
CNX and CRT that decide the interaction with
ATP, Zn2+ and polypeptide regions of substrate
proteins will also be essential. Such information
could for instance be obtained by structure
determination in the presence of these co-fac-
tors, which might also provide direct informa-
tion on the local and global conformational
changes that occur upon cofactor binding. These
results should in turn allow the design of muta-
tions that specifically remove the co-factor inter-
actions individually. Provided that such
mutants can be shown to retain structural and
functional properties of the wild-type protein,
they will become valuable tools for the charac-
terization of functions related to cofactor bind-
ing both in vivo and in vitro. Application of this
experimental strategy will be particularly
important to investigate functions such as ATP
binding, which can otherwise not easily be tar-
geted in vivo without perturbing the cellular
environment. To fully appreciate the role of ATP
binding by CNX and CRT the identification of
potential co-chaperones for ATP hydrolysis,
nucleotide exchange or dissociation will be crit-
ical. Taken together, the results of such experi-
ments should provide us with a more detailed
understanding of how the CNX/CRT chaper-
one system functions at the molecular level.
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